Key Takeaways Men are more likely than women to get sick and die from three common conditionsHigh blood pressure, diabetes ...

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

Apple reported second-fiscal-quarter earnings Thursday that beat expectations. Amazon reported better-than-expected results ...

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

Newly identified neurons process multiple food cues to determine when an animal should stop eating, offering new clues into ...

The UK government is set to remove the exemption for sweetened dairy and plant-based milk from its sugar tax – what does this ...

The largest health bill Congress will consider this year doesn’t mention hospitals or doctors. The Farm Bill, which lapsed in ...

Terns Pharmaceuticals, Inc.’s TERN share price has surged by 5.15%, which has investors questioning if this is right time to ...

Obesity is common in our society for humans and our pets. Spring is a good time to consider the impacts of winter ...

The pharmaceutical firm Novo Nordisk is pursuing a multi-pronged strategy to regain market share that it has lost to Eli ...